Eden Research (LON:EDEN) Reaches New 1-Year Low – Here’s What Happened

Eden Research plc (LON:EDEN) reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 2.20 and last traded at GBX 2.20, with a volume of 354160 shares traded. The stock had previously closed at GBX 2.40.

Eden Research Stock Performance

The firm’s fifty day moving average price is GBX 2.65 and its 200-day moving average price is GBX 3.21. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The company has a market cap of £11.73 million, a P/E ratio of -4.96 and a beta of 0.92.

Eden Research (LON:EDEN) last released its earnings results on Wednesday, September 17th. The company reported GBX (0.25) earnings per share for the quarter. Eden Research had a negative net margin of 38.70% and a negative return on equity of 11.63%. As a group, research analysts forecast that Eden Research plc will post -66.0000038 EPS for the current fiscal year.

Insider Activity at Eden Research

In other news, insider Alexander John Abrey acquired 360,490 shares of the stock in a transaction dated Wednesday, September 17th. The shares were acquired at an average cost of GBX 3 per share, for a total transaction of £10,814.70. Also, insider Sean M. Smith bought 390,624 shares of the business’s stock in a transaction that occurred on Wednesday, September 17th. The stock was purchased at an average price of GBX 3 per share, with a total value of £11,718.72. 4.46% of the stock is currently owned by company insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.